| ID | Title | Body | Facebook Description | Facebook image | Facebook Title | Facebook Video | Twitter Description | Twitter Image | Twitter Title | Meta tags |
|---|---|---|---|---|---|---|---|---|---|---|
| 682 | Past Events | 2023 March NCATS Budget Briefing for Fiscal Year 2024 March 14 February Rare Disease Day at NIH Feb. 28 Website • Agenda (PDF - 204KB) • Videocast Virtual 2023 NIH Grants Conference: Funding, Policies & Processes Feb. 1–2 Website • Agenda January NCATS Advisory Council Meeting Jan. 26 Agenda (PDF - 182KB) • Minutes (PDF - 328KB) • Videocast • Federal Register Notice 2022 November The Quest for Innovative Molecular Treatment Modalities for Intractable Disease Targets Nov. 17–18 Website • Agenda • Watch Day 1 • Watch Day 2 If you require a 508-remediation version of the webinar, please contact Karlie Sharma. October NCATS Online Course in Preclinical Translational Science Oct. 26–Dec. 13 MEDI 501: Principles of Preclinical Translational Science • Download the course syllabus (PDF - 238KB) • Download the course flyer (PDF - 428KB) NCATS–NIAID Joint Workshop on Bacteriophage Therapy: Challenges and Solutions to the Development of Bacteriophage Therapy Oct. 25 Website • Agenda Assay Guidance Workshop for High-Throughput Screening and Lead Discovery Oct. 18–19 Website and Agenda Technical Assistance Webinar for the Clinical and Translational Science Award Program Oct. 12 Per NOT-TR-22-034, NCATS conducted a technical assistance webinar for applicants responding to: Clinical and Translational Science Award (UM1 Clinical Trial Optional) (PAR-21-293) Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed) (PAR-21-340) Limited Competition:NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed) (PAR-21-339) Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) (PAR-21-338) Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) (PAR-21-337) Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional) (PAR-21-336) This webinar provided an overview of these funding opportunity announcements that invite applications for the Clinical and Translational Science Award (CTSA) Program hubs. September NCATS Advisory Council Meeting Sept. 22 Agenda (PDF - 181KB) • Minutes (PDF - 348KB) • Videocast • Federal Register Notice June NCATS Online Course in Translational Science in the COVID-19 Pandemic June 15–Aug. 2 Syllabus (PDF - 222KB) • Flyer (PDF - 371KB) Assay Guidance Workshop on 3-D Tissue Models for Antiviral Drug Development June 7–8 Website • Agenda (PDF - 273KB) • Videocast (Day 1) • Videocast (Day 2) May NCATS Advisory Council Meeting May 19–20 Agenda (PDF - 190KB) • Minutes (PDF - 471KB) • Videocast (Day 1) • Videocast (Day 2) • Federal Register Notice Teatime with NCATS Acting Director Joni Rutter May 18 The 45-minute event featured a short presentation from Joni L. Rutter, Ph.D., NCATS acting director, followed by a conversation moderated by Esther Krofah, M.P.P. , executive director of FasterCures and the Center for Public Health at the Milken Institute, about how we can build relationships, raise awareness and work together to advance the mission of NCATS. Video • Audio Described Video Regulatory Fitness in Rare Disease Clinical Trials May 16–17 Website • Agenda (PDF - 190KB) • Resources • Webcast March NCATS Online Course in Translational Science March 28–May 13 Website • Syllabus (PDF - 261KB) • Flyer (PDF - 419KB) Translational Science Education Roundtable March 10–11 Agenda and Participation List (PDF - 185KB) • Presentation: Joni L Rutter, Ph.D. (PDF - 4.2MB) • Presentation: Jessica Faupel-Badger, Ph.D., MPH (PDF - 2.3MB) • Roundtable Summary (PDF - 258KB) February Rare Disease Day at NIH Feb. 28 Website • Agenda (PDF - 219KB) • Videocast Webinar: Peer Review for Small Business Funding: An Overview of the Process Feb. 24 Tribal Consultation on the NCATS National COVID Cohort Collaborative (N3C) Feb 11 Website • Videocast • Presentation Assay Guidance Workshop for High-Throughput Screening and Lead Discovery (Short Course) Feb. 5 Website January NCATS Online Course in Translational Science in the COVID-19 Pandemic Jan. 31–March 18 Website • Download the course syllabus • Download the course flyer NCATS Advisory Council Meeting Jan. 20–21 Agenda (PDF - 179KB) • Minutes (PDF - 529KB) • Videocast (Day 1) • Videocast (Day 2) • Federal Register Notice 2021 December A Decade of Innovation: How NCATS Is Impacting Translational Science through Small Business Growth Dec. 8 Watch the webinar • Download the transcript (Word — 64KB) • Download the presentation slides (PDF — 1.8MB) NCATS at 10: Improving Health for All Through Translational Science Dec. 7 Website • Agenda (PDF - 148KB) November Assay Guidance Workshop for Cell-Based Assays and Lead Discovery Nov. 16–17 Website Fall 2021 NIH Virtual Seminar on Program Funding and Grants Administration Nov. 1–4 Website October NCATS Online Course in Translational Science in the COVID-19 Pandemic Oct. 25–Dec. 10 Website • Download the course syllabus (PDF - 176KB) • Download the course flyer (PDF - 457KB) September NCATS Advisory Council Meeting Sept. 23–24 Agenda (PDF - 131KB) • Minutes (PDF - 358KB) • Videocast (Day 1) • Videocast (Day 2) • Federal Register Notice 2021 NIH-BIO Summer Series: Improving Diversity in Biotech by Leveraging SBIR/STTR Opportunities Sept. 14 Assay Guidance Manual Virtual Workshop on DNA-Encoded Libraries for Lead Discovery Sept. 1–2 Agenda August NCATS Online Course in Translational Science Aug. 30–Oct. 15 Website • Syllabus (PDF - 205KB) • Flyer (PDF - 512KB) June NCATS Online Course in Translational Science June 14–July 30 Website • Download the course syllabus (PDF - 176KB) • Download the course flyer (PDF - 334KB) LitCoin Stakeholder Feedback Workshop June 17–18 Website & Agenda Gene-Targeted Therapies: Early Diagnosis and Equitable Delivery June 3, June 10 and June 17 Website • Agenda - Day 1 (PDF - 248KB) • Agenda - Day 2 (PDF - 258KB) • Agenda - Day 3 (PDF - 249KB) • VideoCast (Day 1) • VideoCast (Day 2) • VideoCast (Day 3) NCATS Advisory Council Meeting June 10–11 Agenda (PDF - 176KB) • Minutes (PDF - 512KB) • Videocast (Day 1) • Videocast (Day 2) • Federal Register Notice May Federal Technology Transfer: Measuring Impact, Innovation & Efficiencies May 13–14 Website • Agenda • WebEx Recording (Day 1) • WebEx Recording (Day 2) • Workshop Report April Pre-Application Webinar for RFA-TR-21-001: New Chemistries for Un-drugged Targets through A Specialized Platform for Innovative Research Exploration (ASPIRE) Collaborative Research Program April 7 RFA-TR-21-001 • RFA-TR-21-002 March NIH Space Chat with Astronaut Kate Rubins March 26 YouTube Video Pre-Application Webinar for NCATS RFA-TR-21-008, Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey March 12 Webpage Rare Disease Day at NIH March 1 Website • Agenda (PDF - 484KB) • VideoCast February Rare Diseases Reddit “Ask Me Anything” Feb. 23 Highlights January NCATS Advisory Council Meeting Jan. 14–15 Agenda (PDF - 246KB) • Minutes (PDF - 298KB) • WebEx Recording (Day 1, Not available) • WebEx Recording (Day 2) • Federal Register Notice 2020 November Virtual Workshop on Systemic Immunogenicity Considerations for AAV-Mediated Gene Therapy Nov. 30 – Dec. 1 Website • Agenda (PDF - 171KB) • VideoCast (Day 1) • VideoCast (Day 2) 2020 NIH Rural Health Seminar: Challenges in the Era of COVID-19 Nov. 18–19 Website Assay Guidance Workshop for High-Throughput Screening and Lead Discovery Nov. 18–19 Website NIH Virtual SARS-CoV-2 Antiviral Therapeutics Summit Nov. 6 Website • Agenda (PDF - 185KB) • Hosts & Presenters • NIH VideoCast • Summit Report (PDF - 1.5MB) October Pre-Application Webinar for NCATS RFA-TR-20-031 and RFA-TR-20-032, Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases Oct. 15 Frequently asked questions for RFA-TR-20-031 (PDF - 134KB) For more information about the webinar, see NOT-TR-20-038. Pre-Application Webinar for NCATS RFA-TR-20-030, Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey Oct. 6 View the webinar slides (PDF - 968KB) • Download responses to questions asked during the webinar (PDF - 146KB) For more information about the webinar, see NOT-TR-20-037. September NCATS Advisory Council Meeting Sept 17–18 Agenda (PDF - 231KB) • Minutes (PDF - 311KB) • WebEx Recording (Day 1) • WebEx Recording (Day 2) • Federal Register Notice NCATS Online Course in Translational Science Sept. 8 – Oct. 23 Download the course flyer (PDF - 508KB) • Read the course syllabus (PDF - 152KB) July Transforming Translational Science July 24 Website June NCATS Online Course in Translational Science June 15 – July 31 Download the course flyer (PDF - 334KB) • Course Syllabus (PDF - 162KB) May NCATS Advisory Council Meeting May 14 Agenda (PDF - 286KB) • Minutes (PDF - 338KB) • WebEx Recording • Federal Register Notice March Linking Research to Rural Communities with the NIH National Center for Advancing Translational Sciences Webinar March 31 February Rare Disease Day at NIH Feb. 28 Website • Agenda (PDF - 218KB) • Videocast • Feature Story January Expanding AAV Manufacturing Capacity for Rare Disease Gene Therapies Jan. 28–29 Website • Videocast NCATS Advisory Council and CAN Review Board Meeting Jan. 16 Agenda (PDF - 218KB) • Minutes (PDF - 295KB) • WebEx Recording • Advisory Council Federal Register Notice • CAN Review Board Federal Register Notice Assay Guidance Workshop for High-Throughput Screening and Lead Discovery Jan. 25 Website/Agenda 2019 December NCATS Day 2019: Conversations on Responsible Data Sharing Dec. 17 Website • Agenda • Videocast Cures Acceleration Network Review Board Meeting Dec. 13 Agenda (PDF - 149KB) • Minutes (PDF - 311KB) • WebEx Recording • Federal Register Notice Repurposing Off-Patent Drugs: Research & Regulatory Challenges Dec. 5–6 Website/Agenda/Registration • Videocast November Inaugural NIH Rural Health Seminar Nov. 18 Website/Agenda • Videocast September Ask an Astronaut: Biomedical Science Edition Sept. 23 Website NCATS Advisory Council and CAN Review Board Meeting Sept. 19 Agenda (PDF - 253KB)• Minutes (PDF - 265KB) • Videocast • Advisory Council Federal Register Notice (amended) • CAN Review Board Federal Register Notice Assay Guidance Workshop for High-Throughput Screening and Lead Discovery Sept. 11–12 June Machine Intelligence in Healthcare: Perspectives on Trustworthiness, Explainability, Usability and Transparency June 11 Website • Agenda (PDF - 140KB) • Webcast CNS Immunogenicity Considerations for AAV-mediated Gene Therapy June 11 Website • Agenda (PDF - 164KB) • Videocast May NCATS Advisory Council and CAN Review Board Meeting May 16 Agenda (PDF - 190KB) • Minutes (PDF - 454KB) • Videocast • Federal Register Notice RE(ACT) Congress AMERICA — International Congress on Research of Rare and Orphan Diseases May 8–11 Website • Program April Accelerating Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome April 4–5 Website • Agenda • Webcast (Day 1) • Webcast (Day 2) March Assay Development Principles and Good Research Practices for Rigor and Reproducibility in In Vitro Toxicology (AM03) March 10 Website/Agenda February Rare Disease Day at NIH Feb. 28 Website • Agenda (PDF - 176KB)• Videocast • Feature Story Twitter Chat on Rare Diseases Feb. 22 Website The Opioid Crisis and the Future of Addiction and Pain Therapeutics: Opportunities, Tools, and Technologies Symposium Feb. 7–8 Website • Agenda (PDF - 135KB) Natural Products and Pain: The Search for Novel Non-Opioid Analgesics Feb. 6 Website/Agenda Assay Guidance Workshop for High-Throughput Screening and Lead Discovery Feb. 2 Website/Agenda January NCATS Advisory Council and CAN Review Board Meeting Jan. 10 Agenda (PDF - 159KB) • Minutes (PDF - 340KB) • WebEx Recording • Federal Register Notice 2018 December Cures Acceleration Network Review Board Meeting Dec. 14 Agenda (PDF - 107KB) • Minutes (PDF - 374KB) • WebEx Recording • Federal Register Notice November Driving Innovation: NCATS Programs to Support Small Businesses Nov. 27 October Collaborations across NCATS’ Trial Innovation Network Oct. 30 CTSA Program Vision: Current Initiatives and Future Goals Oct. 9 September NCATS Day 2018: Engaging Patients and Communities for Smarter Science Sept. 28 Website • Agenda (PDF - 36KB) • Videocast • Posters (PDF - 400KB) • Photos • Participant Roster (PDF - 847KB) • Community Engagement Resources • Patient Engagement Resource (PDF 421KB) • NCATS Fact Sheet (PDF - 351KB) NCATS Advisory Council and CAN Review Board Meeting Sept. 27 Agenda (PDF - 179KB) • Minutes (PDF - 268KB) • Videocast • Federal Register Notice Single IRB Review for Multi-Site Research Resource and Infrastructure Development Workshop Sept. 12 Website Assay Guidance Workshop for High-Throughput Screening and Lead Discovery Sept. 10–11 Website • Agenda August The Growing Promise of Gene Therapy Approaches to Rare Diseases Aug. 20–21 Website • Agenda (PDF - 168KB) • Videocast June Addressing the Opioid Crisis Through Translational Science “Un-Meeting” June 2 Website May NCATS Advisory Council and CAN Review Board Meeting May 10 Agenda (PDF - 145KB) • Minutes (PDF - 303KB) • Videocast • Federal Register Notice Leveraging Community Engagement and Informatics-Based Tools to Increase Participant Recruitment and Retention May 4 Website April Organs- and Tissues-on-Chips Conference April 8–12 Website/Agenda March Assay Guidance Workshop for High-Throughput Screening and Lead Discovery March 26–27 Agenda Rare Disease Day at NIH March 1 Website • Agenda (PDF - 150KB) • Videocast • Feature Story February Twitter Chat on Rare Diseases Feb. 23 Website 3-D Printing: Medicine’s New Dimension Feb. 13 Website January NCATS Advisory Council and CAN Review Board Meeting Jan. 11 Agenda (PDF - 145KB) • Minutes (PDF - 224KB) • Videocast • Federal Register Notice 2017 December Cures Acceleration Network Review Board Virtual Meeting Dec. 15 Agenda (PDF - 101KB) • Minutes (PDF - 170KB) • Federal Register Notice November NIH Extracellular RNA Communication Consortium 9th Investigators’ Meeting Nov. 6–7 Website October Second Strategic Partnerships for Drug Repurposing Forum Oct. 26–27 Website • Agenda NCATS Data Translator Meeting Oct. 25 Website/Agenda Assay Guidance Workshop for High-Throughput Screening and Lead Discovery Oct. 23 Website • Agenda Automated Chemical Synthesis Workshop Oct. 19–20 Translational Research Symposium 2017: Found in Translation Oct. 4 Website September Workshop on Translational Challenges of Induced Pluripotent Stem Cells Sept. 26 Videocast Translational Medicine 2017: Enhancing Predictivity in Medicines Development Sept. 24–26 European Reference Networks on Rare Neurological Diseases Webinar Sept. 13 Website NCATS Toolkit for Patient-Focused Therapy Development: Demonstration and Dissemination Meeting Sept. 8 Website • Agenda (PDF - 77KB) • Videocast NCATS Advisory Council and CAN Review Board Meeting Sept. 7 Agenda (PDF - 164KB) • Minutes (PDF - 188KB) • Videocast • Federal Register Notice August The Science of Caregiving: Bringing Voices Together Aug. 7–8 Website • Agenda (PDF - 257KB) Assay Guidance Workshop for High-Throughput Screening and Lead Discovery Aug. 7 Agenda July Quantitative Systems Pharmacology and Drug Discovery: Filling the Gaps in Current Models of the R&D Process for Neurotherapeutics July 26–27 Website Global Foundation for Peroxisomal Disorders (GFPD) 2017 Scientific Conference: Development of Therapies for Peroxisome Biogenesis Disorders July 13–14 Website June NCATS Day — Partnering with Patients for Smarter Science June 30 Website • Agenda (PDF - 549KB) • Event Photos May NCATS Advisory Council and CAN Review Board Meeting May 4 Agenda (PDF - 114KB) • Minutes (PDF - 216KB) • Videocast April The NIH Microphysiological Systems Program: Tissues-on-Chips for Drug Safety and Efficacy Studies April 24 March Engineered Cells and Tissues as Platforms for Discovery and Therapy (K1) March 9–12 Agenda Rare and Undiagnosed Diseases: Discover and Models of Precision Therapy (C2) March 5–8 Agenda February Rare Disease Day at NIH Feb. 27 Website • Agenda (PDF - 134KB) • Videocast Twitter Chat on Rare Diseases Feb. 21 Website Third International Rare Diseases Research Consortium (IRDiRC) Conference Feb. 8–9 Website • Agenda Assay Guidance Workshop for High-Throughput Screening and Lead Discovery Feb. 4 Website January NCATS Advisory Council and CAN Review Board Meeting Jan. 12 Agenda (PDF - 77KB) • Minutes (PDF - 220KB) • Meeting Information 2016 December NCATS SBIR/STTR Twitter Chat Dec. 12 Cures Acceleration Network (CAN) Review Board Virtual Meeting Dec. 9 Agenda (PDF - 115KB) • Minutes(PDF - 214KB) • Federal Register Notice Therapeutically Relevant Bioassays Webinar Dec. 7 Website October Assay Guidance Workshop for High-Throughput Screening and Lead Discovery Oct. 27 International Conference on Rare Diseases and Orphan Drugs (ICORD) Oct. 19–22 Website New Frontiers in 3-D Cell Culture–Based Screening Technologies Oct. 13 September NCATS Advisory Council and CAN Review Board Meeting Sept. 15 Agenda (PDF - 156KB) • Minutes (PDF - 169KB) • Videocast • Federal Register Notice Tissue Chips in Space Informational Webinar Sept. 6 NIH Guide Notice • Related Information August SBIR Contract Solicitation Pre-Proposal Webinar Aug. 24 NIH Guide Notice July Securing SBIR and STTR Funding: Support for Women Entrepreneurs and Researchers in Biotech July 14 Transform Tox Testing Challenge: Innovating for Metabolism Semi-Finalists Workshop July 8 Website June NCATS Advisory Council and CAN Review Board Meeting June 13 Agenda (PDF - 150KB) • Minutes (PDF - 192KB) • Federal Register Notice Best Practices of Biomedical Research: Improving Reproducibility and Transparency of Preclinical Research Conference June 9–10 Trans-Agency Blood Brain Interface Workshop 2016 June 7–8 Videocast April Pfizer CTI at NIH Workshop April 14 Assay Guidance Workshop for High-Throughput Screening and Lead Discovery April 5–6 Agenda (PDF - 45KB) March NIH Translational Science Training Program Boot Camp March 31 – April 1 Website Society of Toxicology 55th Annual Meeting and ToxExpo March 13–17 Website RE(ACT) Congress — International Congress on Research of Rare and Orphan Diseases March 9–12 Website Accelerating Innovation: Funding for Women Entrepreneurs in Biotechnology and Health Care Webinar March 2 February WORLDSymposium™ 2016 Feb. 29 – March 4 Website Rare Disease Day at NIH Feb. 29 Website • Agenda (PDF - 178KB) • Videocast NIH Twitter Chat: Rare Diseases Feb. 22 Website January NCATS Advisory Council and CAN Review Board Meeting Jan. 14 Agenda (PDF - 80KB) • Minutes (PDF - 220KB) • Meeting Information 2015 December Cures Acceleration Network (CAN) Review Board Virtual Meeting Dec. 11 Agenda (PDF - 65KB) • Minutes (PDF - 192KB) • Slides (PDF - 572KB) • Federal Register Notice November Common Rule Meeting: Enhancing and Clarifying Consent Forms and Establishing Standard Safeguards Nov. 18 RARE Webinar: Introducing NCATS’ ORDR Director Petra Kaufmann Nov. 17 12th Annual Meeting DIA Japan 2015 Nov. 15–17 Website NCATS Strategic Plan Town Hall Webinar Nov. 10 View Slides (PDF - 910KB) NCATS Small Business Funding Opportunities Webinar Nov. 10 2015 CURED Eosinophilic Gastrointestinal Disease Patient Research Symposium Nov. 6–8 Website Common Rule Meeting: Revising and Expanding the Scope of the Common Rule Nov. 5 NCATS Strategic Plan Town Hall Webinar Nov. 4 View Slides (PDF - 910KB) 2015 Federal Laboratory Consortium for Technology Transfer (FLC) Mid-Atlantic Regional Meeting & I2C Conference Nov. 2–3 Seventh Annual Partnering for Cures Conference Nov. 1–3 Website October Common Rule Meeting: Streamlining Institutional Review Board Review Oct. 29 10th Annual Translational Stem Cell Research Conference Oct. 28–29 Website NCATS Strategic Plan Town Hall Webinar Oct. 26 View Slides (PDF - 910KB) Rare Diseases and Orphan Products Breakthrough Summit Oct. 21–22 Website Common Rule Meeting: Requiring Consent for Research with Biospecimens and Allowing Broad Consent Oct. 14 2015 Erdheim Chester Disease Medical Symposium and Patient & Family Gathering Oct. 8 Website September 27th Annual Fanconi Anemia Research Fund Scientific Symposium Sept. 17–20 Website C&EN Virtual Symposium: Advances in Drug Discovery and Development Sept. 16 NCATS Advisory Council and CAN Review Board Meeting Sep. 3 Meeting Information August Genomic Integrity Aug. 1–5 July Fourth International RASopathies Symposium July 17–19 Website Assay Guidance Workshop for High-Throughput Screening and Lead Discovery July 17 Personalized Medicine: Novel Biologic Therapies for Rare Eosinophilic Disorders July 14 June Technical Assistance Video for CTSA Recruitment Innovation Centers June 22 Access the Video NCATS Advisory Council and CAN Review Board Meeting June 18 Meeting Information Webinar: Funding Opportunities for Early-Stage Companies June 11 May Second EATRIS Conference: Building Bridges in Translational Medicine May 27–28 Webinar: Funding and Resources to Catalyze Translation from Lab to Patient May 13 April International Society for Extracellular Vesicles (ISEV) Annual Meeting and Joint Education Day April 23–26 Translational Science 2015 April 16–18 Website Pfizer's Centers for Therapeutic Innovation (CTI) Seminar and One-on-One Meetings for NIH Intramural Researchers April 13–14 February Rare Disease Day at NIH Feb. 27 Website • Agenda (PDF - 123KB) • Videocast Fifth AIMBE/NIH Workshop on Validation and Qualification of New In Vitro Tools and Models for the Preclinical Drug Discovery Process Feb. 12 Society for Laboratory Automation and Screening (SLAS) 4th Annual Conference & Exhibition Feb. 7–11 January NCATS Advisory Council and CAN Review Board Meeting Jan. 15 Meeting Information Workshop to Explore the Ethical, Legal and Social Implications of Citizen Science Jan. 13–14 Website 2014 December Cures Acceleration Network (CAN) Review Board Meeting Dec. 12 Agenda (PDF - 108KB) • Minutes (PDF - 256KB) Intellectual Property Webinar Series: Patents, Trademarks, and Copyrights Dec. 9–11 November Partnering for Cures Nov. 16–18 Website Small Business Grants (SBIR/STTR) Webinar for Applicants Nov. 7 Webinar October Next-Generation R&D Partnerships: The NCATS Success Story Oct. 29 Website Addressing Irreproducibility in Target Validation Oct. 23 Website 16th Annual NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Conference Oct. 21–23 September NCATS Advisory Council and CAN Review Board Meeting Sept. 19 Agenda (PDF - 93KB) • Minutes (PDF - 255KB) August National Conference on Engaging Patients, Families, and Communities in all Phases of Translational Research to Improve Health Aug. 21–22 Website May NCATS Advisory Council and CAN Review Board Meeting May 16 Minutes (PDF - 643KB) • Federal Register Notice • Agenda (PDF - 67KB) • Working Group Report on the IOM CTSA Report (PDF - 414KB) March Fourth AIMBE/NIH Workshop on Validation and Qualification of New In Vitro Tools and Models for the Preclinical Drug Discovery Process March 6–7 Website NIH SBIR/STTR Pre-Submission Update Webinar March 6 Videocast • Resources February Rare Disease Day at NIH Feb. 28 Website • Agenda (PDF - 188KB) • Videocast January NCATS Advisory Council and CAN Review Board Meeting Jan. 16 Agenda (PDF - 67KB) • Minutes (PDF - 220KB) • Videocast • Federal Register Notice 2013 December Cures Acceleration Network (CAN) Review Board Meeting Dec. 12 Agenda (PDF - 56KB) • Minutes (PDF - 455KB) Reddit AMA (Ask Me Anything): Rare Diseases and the Research Process Dec. 4 Chat Link November Technical Assistance Webinar for RFA-RM-13-011 "Development of a Knowledge Management Center for Illuminating the Druggable Genome (U54)" Illuminating the Druggable Genome (IDG) Pre-Application Meeting Nov. 1 October Global Genes | RARE Webinar Series Understanding Rare Disease Registries (Part Two) Oct. 23 Website September NCATS Advisory Council and CAN Review Board Meeting Sept. 16 Agenda (PDF - 72KB) • Minutes (PDF - 431KB) • Videocast NCATS Research and Development Day Sept. 12 Website • Agenda (PDF - 314KB) August 6th Annual Clinical and Translational Science Award (CTSA) National Conference Science of Community Engaged Research: Future Directions Aug. 22–23 Website July Global Genes | RARE Webinar Series Understanding Rare Disease Registries (Part One) July 31 Website June Adaptive Designs for Clinical Trials: Opportunities for Translational Research June 10 6th Annual Clinical Research Management Workshop June 3–4 May NCATS Advisory Council and CAN Review Board Meeting May 17 Agenda (PDF - 138KB) • Minutes (PDF - 306KB) • Videocast April Translational Science 2013: Increasing the Value of Your Research through Team Science April 17–19 Website NIH Biospecimens Interest Group (BIG) April 4 February Rare Disease Day at NIH Feb. 28–March 1 Website • Agenda (PDF - 206KB) • Videocast - Day 1 • Videocast - Day 2 January NCATS Advisory Council and CAN Review Board Meeting Jan. 23 Agenda (PDF - 98KB) • Minutes (PDF - 530KB) • Videocast 2012 November FDA-NIH Workshop: The Science of Small Clinical Trials Nov. 27–28 Website October 2012 Sleep Research Network Meeting Oct. 22–23 3rd Annual Conference on Clinical Research for Rare Diseases Oct. 2 NIH Microphysiological Systems Program: First Investigators’ Meeting Oct. 1–2 September NCATS Advisory Council and CAN Review Board Meeting Sept. 14 Council Agenda (PDF - 94KB) • CAN Review Board Agenda (PDF - 254KB) • Minutes (PDF - 228KB) (Corrigendum) (PDF - 81KB) • Videocast • Federal Register Notice Gene Transfer and Rare Diseases Workshop Sept. 13 August 5th Annual National CTSA Community Engagement Conference: Methods, Metrics and Outcomes: Evaluating the Success of Community Engaged Research Aug. 23–24 July CTSA Public-Private Partnerships Webinar Series Prize4Life & NIH Program on Public-Private Partnerships July 25 CTSA Technical Assistance Webinar for RFA-TR-12-006 July 23 June CTSA Public-Private Partnerships Webinar Series Looking for the Win-Win: How Regeneron's Public-Private Partnerships Fuel Innovation June 27 Therapeutics Discovery Technical Assistance Webinar June 25 5th Annual Clinical Research Management Workshop: Learning by Doing: Applying Evidence-based Tools to Re-engineer Clinical Research Management June 4–5 Maximizing the Goals of the Cures Acceleration Network to Accelerate the Development of New Drugs and Diagnostics: A Workshop June 4–5 Website May Rare Diseases: The Challenges Presented by Biospecimens, Patient Registries, Electronic Heath Records and Bioethics May 31 Videocast CTSA Public-Private Partnerships Webinar Series The International Clinical Compound Library (ICCL): Accelerating the Development of New Therapies for Many Global Unmet Medical Needs May 23 NCATS’ Therapeutics for Rare and Neglected Diseases Program Road Show May 22 Workshop on Natural History Studies of Rare Disease: Meeting the Needs of Drug Development and Research May 16–17 March Collaboration in Action March 21 February Rare Disease Day at NIH Feb. 29 Website • Agenda (PDF - 207KB) • Videocast Virtual Town Hall with NCATS Leadership Feb. 27 Fiscal Year 2013 Budget in Brief: Strengthening Health and Opportunity for All Americans Feb. 13 NCATS Congressional Justification (PDF - 783KB) 2011 February Rare Disease Day at NIH Feb. 28 Website • Agenda (PDF - 120KB) | ||||||||
| 680 | Events | h5 { font-weight: bold; } May 2023 Showcase and Ideas Exchange About Bias in Health Care Artificial Intelligence Webinar NCATS Strategic Planning Roundtable Discussions NCATS Advisory Council Meeting June 2023 2023 AGM Preclinical Translational Science Webinar Series May 2023 Showcase and Ideas Exchange About Bias in Health Care Artificial Intelligence Webinar May 5 12:30 p.m. EDT NCATS will be announcing the winners of the Bias Detection Tools for Clinical Decision-Making Challenge at a webinar on May 5, 2023, at 12:30 p.m. EDT. The bias detection challenge — launched in October 2022 — will award up to $700,000 to those teams best able to create an open-source solution that detects and mitigates bias in artificial intelligence/machine learning (AI/ML) models used in health care settings. More than 200 people signed up to compete in this challenge, and the resources and webinars provided during the challenge aimed to offer context and cross-training for this complex issue that includes AI/ML, health care, and bias and ethics. Attendees will: Learn from competitors about issues that surfaced and discoveries that were made while developing their solutions. Share their thoughts and ideas with NCATS on how to continue to propel the field of bias detection and mitigation in health care AI forward. Discover how they can join future efforts to improve health care and mitigate bias through AI. Webinar Registration NCATS Strategic Planning Roundtable Discussions May 9 Session: 12 to 1:30 p.m. EDT May 10 Session: 9:30 to 11 a.m. EDT NCATS will host two virtual stakeholder roundtable discussions on the topic of strategic planning for 2024 through 2029. The meetings will include an overview of the vision for the center from NCATS Director Joni L. Rutter, Ph.D.; information on the strategic planning process; and small group discussion. NCATS’ stakeholders include, but are not limited to, patients and members of the health advocacy community; basic, translational and clinical scientists at universities and research institutions; health care providers; biotechnology, venture capital and pharmaceutical industry members; colleagues at other NIH institutes, centers and offices; partners at other government agencies; policymakers; and the public. Registration NCATS Advisory Council Meeting May 25 Closed Session: 11 a.m. to 12 p.m. EDT Open Session: 1-6 p.m. EDT The NCATS Advisory Council will convene a virtual meeting on May 25, 2023. The meeting will feature presentations from NCATS Director Joni L. Rutter, Ph.D., and others about the center’s initiatives, policies, programs and future direction. For more information about the Advisory Council, visit the NCATS Advisory Council page of this site. Federal Register Notice June 2023 2023 AGM Preclinical Translational Science Webinar Series June 2 11 a.m. to 12 p.m. EDT NCATS’ Assay Guidance Manual (AGM) program will host a quarterly virtual webinar series in conjunction with the center’s Office of Policy, Communications and Education and Office of Drug Development Partnership Programs. This series, featuring prominent speakers in the field, is designed to communicate critical information about preclinical translational science and is particularly relevant for biomedical researchers who are conducting preclinical studies to advance research leading to interventions that will impact human health. The webinar series will convey best practices in preclinical translational science to help bridge the gap between research discoveries and the delivery of new therapies. Participants will discuss topics relevant to preclinical translational science, including reproducibility, assay development, new and emerging modalities in drug discovery, and entrepreneurship. Participants also will dissect case studies about successful and unsuccessful drug discovery campaigns, with the goal of learning about strategies, methods, and approaches for accelerating drug development. Presenters will provide an overview of the AGM e-book, an important resource for detailed information about robust assay methods and best practices in quantitative biology. They also will disseminate the principles of translational science among scientists in biomedical research and demonstrate how these are applied in preclinical research. Website/Agenda • Registration !function(c,h,i,m,p){m=c.createElement(h),p=c.getElementsByTagName(h)[0],m.async=1,m.src=i,p.parentNode.insertBefore(m,p)}(document,"script","https://chimpstatic.com/mcjs-connected/js/users/e06bd55ccbb41f1a362306dff/9c199175ea7b167e2bdb5384e.js"); | View NCATS' events, including webinars, health observations, and press conferences. | Events | View NCATS' events, including webinars, health observations, and press conferences. | Events | ||||
| 673 | Videos | Watch videos of NCATS leadership, researchers and grantees in action, including high-quality b-roll of the Center’s robotic screening platform. The media player works best when viewed in Chrome or Internet Explorer browsers. I Am Translational Science Video Series Perspectives from NCATS Intramural Research Fellows Program Videos Rare Disease Patient Videos B-Roll Additional videos are available on the NCATS YouTube channel. | ||||||||
| 662 | Photos | Visit the NCATS Image Gallery on Flickr to browse the Center’s collection of public images, including photos of NCATS leadership and past meetings and events, plus visuals of ongoing work in the laboratory and clinic. Featured Albums Leadership and Key Staff Clinical and Translational Science Preclinical Science | ||||||||
| 635 | Joint NIH-Pfizer CTI Steering Committee | The CTI network pairs leading researchers with Pfizer resources to pursue scientific and medical advances through joint therapeutic development. The NIH-Pfizer CTI collaboration is governed by a steering committee with equal representation from NIH and Pfizer. The committee selects research projects and makes decisions about their progress. Co-Chairs Uwe Schoenbeck, Ph.D. Senior Vice President and Chief Scientific Officer Centers for Therapeutic Innovation Pfizer Worldwide Research & Development Boston, Massachusetts Anton Simeonov, Ph.D. Scientific Director National Center for Advancing Translational Sciences National Institutes of Health Bethesda, Maryland Members Jeremy Gale, Ph.D. Executive Director Inflammation and Remodeling Pfizer Worldwide Biotherapeutics Research & Development Cambridge, Massachusetts Ronald N. Germain, M.D., Ph. D. Chief, Laboratory of Systems Biology Chief, Lymphocyte Biology Section Acting Chief, Laboratory of Immunology National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda, Maryland Raffit Hassan, M.D. Co-Chief Thoracic and Gastrointestinal Oncology Branch Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda, Maryland John J. O’Shea, M.D. Scientific Director National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institutes of Health Bethesda, Maryland David Shields, Ph.D. CTI East Coast Site Head External Science & Innovation Executive Director, Pfizer Worldwide Research & Development Pfizer, Inc. Cambridge, Massachusetts Will Somers, Ph.D. Vice President and Head Global BioTherapeutics Pfizer Worldwide Research & Development Cambridge, Massachusetts Non-Voting Liaisons Lili Portilla, M.P.A. Director of Strategic Alliances Office of Strategic Alliances National Center for Advancing Translational Sciences National Institutes of Health Bethesda, Maryland Samantha O’Connor, M.B.A. Executive Director and Head Strategy and Business Planning Centers for Therapeutic Innovation Pfizer Worldwide Research & Development Boston, Massachusetts | ||||||||
| 634 | CTI Call for Proposals | Pfizer’s CTI for NIH has two calls for proposals each year. Learn more about the therapeutic areas of interest for this proposal cycle. Advantages to Collaborating with CTI A cooperative research and development agreement (CRADA) collaboration with CTI includes, among other things, access to Pfizer’s drug development expertise and publishing rights. CTI’s foundation partners include: Lupus Research Alliance Crohn’s and Colitis Foundation of America Jeffrey Modell Foundation View frequently asked questions about the CTI program for NIH researchers. See the therapeutic areas of interest. Project Scope As a general rule, CTI does not accept therapeutics of the following kinds: small molecule, radiotherapy, nanoparticle delivery systems and vaccines. Pre-proposals for collaboration will be evaluated initially on the basis of fit with Pfizer internal program portfolios, other CTI collaborations, and business and technical feasibility specific to each project. RNAi, CRISPR technologies and nanoparticles are not in the scope for the current CTI call for proposals. Success Factors: What We Look For Strong project rationale Demonstrated association between target biology pathway and disease mechanism Target validation as demonstrated by genetic or pharmacologic evidence Ability to address unmet medical needs Validated therapeutic drug target Tractable target relative to proposed drug modalities (antibodies, proteins and peptides) Novel target, novel therapeutic strategy or new insight into target patient population Defined target Understanding of desired pharmacology Demonstrated cause-effect relationship to disease mechanism Project feasibility Clear path to candidate development (biochemical/cell-free/cellular assays, disease models, preclinical testing, etc.) Clear path for translation into clinical trials (approach for proof-of-mechanism in humans, accessible patient population, time frame, safety issues, etc.) Clinical differentiation Therapeutic strategies including personalized medicine, patient stratification, molecular signatures, genetic associations and biomarkers Modalities Large molecules (antibodies, proteins, antibody conjugates and fusion proteins) Proposal Submission Process All intramural NIH researchers and clinicians whose work meets these criteria are invited to apply to CTI. The first step is submitting a pre-proposal brief (Word - 39KB), which is a non-confidential two- to three-page overview of the target, mechanism (including evidence for disease linkage), and the proposed therapeutic drug. At a high level, the pre-proposal should explain how the therapeutic hypothesis could be tested in the clinic. Investigators then must submit this pre-proposal to their NIH Institute or Center's technology transfer office for initial review and for submission to the Pfizer CTI Portal. For more information, contact Manjula Donepudi, Ph.D., or Lili Portilla, M.P.A. The NIH-Pfizer Joint Steering Committee reviews all submitted proposals. For selected projects, a team of scientists from CTI and NIH will work together to submit a full proposal and project plan to advance the research. Proposal Stages Stage I: Pre-proposal submission and non-confidential review Stage II: Full proposal submission and confidential review Stage III: Work plan and budget | ||||||||
| 629 | BrIDGs Projects | BrIDGs provides critical resources needed for the development of new therapeutic agents. Successful applicants receive access to NIH contractors who conduct preclinical synthesis, formulation, pharmacokinetic and toxicology services at no cost to the investigator. Browse active projects and completed projects. | ||||||||
| 625 | Completed BrIDGs Projects | Click on the links below to view completed BrIDGs projects: Advanced Studies with 5HMF — Most Potent Anti-Sickling Agent A Pharmacological and Toxicological Evaluation of the Gene Transfer Vectors sc-rAAV2.5IL-1Ra (Rat) and scr-AAV2.5IL-1Ra (Human) in Rats Alternative Formulations of Decitabine to Reactivate Fetal Hemoglobin Production Biomimetic Actinide Decorporation Agents: Enabling Availability cGMP Synthesis of the Selective Kappa Opioid Receptor Antagonist JDTic Developing SRX246 for Stress-Related Affective Illness Development of an ApoA-1 Mimetic Peptide for Treatment of Atherosclerosis Development of Assays to Detect Anti-Drug Antibodies Against ACP-501 Development of Bone Morphogenetic Protein Inhibitors to Treat Blood and Bone Disorders Development of Exendin-(9-39) for the Treatment of Congenital Hyperinsulinism Development of HGF Mimetic (Refanalin) for Hepatic Fibrosis Development of Minihepcidins for the Treatment of Beta Thalassemia Development of Neurosteroids for Lysosomal Storage Disorders Development of P-321 for Chronic Dry Eye Development of Propofol Hemisuccinate for the Treatment of Epilepsy HBN-1 Regulated Hypothermia Formulation and Evaluation of Toxicity IND-Enabling Studies on AAV2-GDNF for Parkinson’s Disease IND-Enabling Toxicology and Safety Pharmacology Studies for a First-in-Class CPG-Activating Drug Treatment (SPINALON) Against Chronic Spinal Cord Injury IND-Enabling Toxicology and Safety Pharmacology Studies of ATN-161 for the Treatment of Crohn’s Disease Inhibitors of Glutaminase 2 as Therapeutic Agents for Neuro-Oncological Diseases and Celiac Sprue Large-Scale Synthesis of Clozapine-N-Oxide Long-Acting Parathyroid Hormone Analog for Treatment of Hypoparathyroidism Manufacture of AAV2-AADC for the Treatment of AADC Deficiency Manufacture of RLIP76-LyoPL for Acute Radiation Syndrome Metarrestin for the Treatment of Pancreatic Cancer Metastin Administration in Humans: Support for Preclinical Toxicology Studies A Novel Drug Candidate for the Treatment of Diabetic Retinopathy Novel PDE Inhibitors for Treatment of Cognitive Dysfunction in Schizophrenia Novel Pre-Hospital Therapy of Myocardial Infarction A Potent Oral Therapy for Cytomegalovirus Infection Preclinical Development of CDD-0102 for the Treatment of Alzheimer’s Disease Preclinical Development of EDN-OL1 for Alzheimer’s Disease Redox Encrypted Therapeutics for Treatment of Friedreich’s Ataxia Safety Pharmacology Studies for Beta Thalassemia Single-Chain Urokinase Plasminogen-Activating Factor Small Molecule Treatment for Rheumatoid Arthritis Using the Preimplantation Factor (PIF) to Treat Graft-Versus-Host Disease | ||||||||
| 624 | BrIDGs Resources | Through the BrIDGs program, researchers partner with NCATS scientists to produce preclinical data as well as research and clinical material. Data and material are generated by NIH contractors under the direction of NCATS intramural researchers with expertise in the following development areas: Synthetic process development Scale-up and manufacture of active pharmaceutical ingredients Development of analytical methods Development of suitable formulations Pharmacokinetic/ADME (absorption, distribution, metabolism and excretion) studies, including bioanalytical method transfer and validation Range-finding initial toxicology studies Investigational New Drug (IND)-directed toxicology studies Manufacture of clinical trial supplies Product development planning and advice in IND preparation BrIDGs collaborations are completed using the contract resources of NCATS and the National Cancer Institute. | ||||||||
| 623 | Work with BrIDGs | The BrIDGs program is accepting new proposals to collaborate. Proposals are due Sept. 30. Review How to Request a Collaboration to begin the process. Collaborators leverage BrIDGs expertise and resources to generate data for a Investigational New Drug applications to a regulatory authority such as the U.S. Food and Drug Administration.BrIDGs enables collaborations on potential therapies for any disease or disorder. Eligible collaborating organizations include academic institutions, not-for-profit organizations and small businesses that meet the criteria for the Small Business Innovation Research program. Foreign academic and nonprofit institutions, as well as NIH intramural researchers, can work with BrIDGs.Learn more about working with BrIDGs: How to Request a Collaboration: Overview of the request process and detailed instructions for investigatorsConsiderations for Collaborators: Minimum data requirements and scope limitations for collaborationsIntellectual Property: How BrIDGs handles background versus new intellectual property created during the projectProject Implementation and Conduct: Project management, oversight and governanceResubmission of Prior Proposals: How to reapply and what must be achieved in the interimBrIDGs Operational ModelBrIDGs staff partner with researchers in need of preclinical therapeutics development expertise and resources to advance candidate therapeutics into clinical trials. Researchers with enough preliminary data can use BrIDGs capabilities to put a preclinical product development plan into action. In general, available expertise and contract resources include synthesis, formulation, pharmacokinetic and toxicology services. Pre-existing intellectual property (IP) rights are retained by the owner, which allows BrIDGs to function as a non-dilutive investment in exciting preclinical therapeutics development projects and to maximize the competitiveness of therapeutic agents for more private-sector funding. |
Last updated on